Jinling Hospital, China
2 clinical trials · 2 recruiting · OTHER
Trials by Jinling Hospital, China
RECRUITINGNCT06676527
Vorolanib in the Second-line Treatment of Patients With Unresectable or Metastatic Renal Cell Carcinoma
This is a multicenter real world study (RWS) initiated by the investigator. Eligible patients will be selected for treatment with second-line treatment including vorolanib and...
Sponsor: Jinling Hospital, ChinaEnrolling: 391 location
NeoplasmsKidney NeoplasmsUrologic Neoplasms+10
RECRUITINGNCT05645055
Biologics for Stricturing Crohn's Diseases
Recent researches have reported that biologics might be also effective for stricturing CD. However, the data were largely retrospective. Prospective studied are needed for...
Sponsor: Jinling Hospital, ChinaEnrolling: 2001 location
The Efficacy of Biologics for Stricturing Crohn's Diseases